Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06812273 · ClinicalTrials.gov registry record · NA
Mediators and Moderators of Auditory Training
A NA study of Hearing Handicap, sponsored by Northeastern University.
- Recruiting
- Registry status
- NA
- Development phase
- 1,260
- Enrollment target
- 3
- Study locations
NCT06812273: Recruiting NA study of Hearing Handicap, sponsored by Northeastern University.
NCT06812273 is a NA study of Hearing Handicap that is actively recruiting participants, run by Northeastern University. The registered enrollment target is 1,260 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (10% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06812273, a NA study of Hearing Handicap, is actively recruiting participants, sponsored by Northeastern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,260 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this clinical trial is to learn how Auditory Training (AT) may help people better understand speech in noisy environments. As people get older, it becomes harder for them to hear speech clearly when there is background noise. This can be frustrating, and it can affect their independence and quality of life. AT is often used to support people with and without hearing loss, especially when a person is not a good candidate for a hearing aid or when amplification from a hearing aid does not improve performance. The investigators want to gather reliable data to understand how AT works and what affects its success. The main questions the trial aims to answer are: * How do different types of sounds influence the effectiveness of auditory training? * Which auditory training approaches are most successful in improving speech understanding? * How do personal traits impact the results of auditory training? The investigators will study a large and diverse group of 1,260 participants, including both young and older adults, to evaluate various auditory training approaches. You will: * Take part in auditory training sessions that include different types of auditory tasks. * Complete tests that measure how well they understand speech in both quiet and noisy settings. * Complete surveys on personal data like demographics, hearing challenges and other factors to help researchers understand what might influence training results. The investigators will measure and compare the results of these approaches to find out which ones are most effective. This could help people who are at risk of cognitive decline, like those at risk for Alzheimer's disease.
Primary Outcome
The DIN tests the ability to identify a series of digits in varying levels of background noise.
Conditions Studied
Interventions
- BEHAVIORAL STM Training
- BEHAVIORAL Speech Training
- BEHAVIORAL Mixed Training
- BEHAVIORAL Gamified Training
- BEHAVIORAL Foraging Training
Study Locations (3)
California
- University of California, Riverside - Riverside
Massachusetts
- Northeastern University - Boston
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,260 participants |
| Start Date | 2025-01-06 |
| Est. Completion | 2027-05-31 |
| Phase | NA |
What NCT06812273 shows while recruiting
NCT06812273 is an interventional study that assigns participants to a tested intervention. Its 1,260 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (10% lower).
The record links to 1 condition, with Hearing Handicap appearing as the primary indexed condition, and to 5 interventions - of which STM Training is the first listed.
NCT06812273 reports a single indexed study location in California, Massachusetts, Oregon.
Frequently Asked Questions
What is clinical trial NCT06812273 about?
NCT06812273 is a clinical study titled "Mediators and Moderators of Auditory Training". The goal of this clinical trial is to learn how Auditory Training (AT) may help people better understand speech in noisy environments. As people get older, it becomes harder for them to hear speech clearly when there is background noise. This can be frustrating, and it can affect their independence ...
What is the current status of trial NCT06812273?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,260 participants. The study started on 2025-01-06. Estimated completion is 2027-05-31.
What conditions does trial NCT06812273 study?
This clinical trial studies the following conditions: Hearing Handicap.
What interventions are being tested in trial NCT06812273?
The interventions under investigation include: STM Training (BEHAVIORAL), Speech Training (BEHAVIORAL), Mixed Training (BEHAVIORAL), Gamified Training (BEHAVIORAL), Foraging Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT06812273?
This trial is sponsored by Northeastern University, which has 39 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06812273 being conducted?
This trial has 3 study locations across California, Massachusetts, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Handicap
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06812273's enrollment target sits among peer trials
1,260 79th of 2000 higher than 1,922 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06712316 · 1,260 participants · Phase 2
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- NCT06931340 · 1,260 participants · Phase 3
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- NCT06119581 · 1,264 participants · Phase 3
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- NCT06790641 · 1,270 participants · NA
Pathways to Perinatal Mental Health Equity
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI